Akero Therapeutics Inc share price logo

Akero Therapeutics Inc Share Price

NASDAQ: AKRO

$54.65

+0.10

(+0.18%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 8 Dec 2025

Akero Therapeutics Inc Stock Performance

as on December 9, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $54.37
    $54.83
    downward going graph

    0.51%

    Downside

    0.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $21.34
    $58.4
    downward going graph

    60.95%

    Downside

    6.86%

    Upside

    downward going graph

Akero Therapeutics Inc share price movements today

Previous Close
$54.55
Open
$54.47
Volume
16.2M
Day's Low - High
$54.37 - $54.83
52 Week Low - High
$21.34 - $58.4

Akero Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Akero Therapeutics Inc Stock Fundamentals & Key Indicators

Check Akero Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Akero Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Akero Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$37.3B371.01%-16.34-264.83%
BUY$52.3B181.08%1237.621.36%
BUY$114.7B92.72%31.4431.35%
BUY$79.4B53.93%17.9532.13%

Analyst Recommendation on Akero Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Akero Therapeutics Inc. Average target price of $56

Akero Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Akero Therapeutics Inc.

What analysts predicted

2.41%UPSIDE

Target Price

$56

Current Price

$54.65

Analyzed by

16 Analysts

Target

$56.00

Akero Therapeutics Inc target price $56, a slight upside of 2.41% compared to current price of $54.65. According to 16 analysts rating.

Akero Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
-
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-31
-39
-55
-53
-55
-72
-70
-70
-70
-81
Net Profit Margin
0.00%
0.00%
-19431.69%
0.00%
0.00%
0.00%
-1750600.00%
0.00%
0.00%
0.00%

Akero Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-80
-100
0
0
0
Operating Income
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-4
-81
-43
-79
-100
-112
-151
-252
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Global Institutional Holdings in Akero Therapeutics Inc

Funds
Holdings
HHG PLC
8.42%
BlackRock Inc
7.23%
General Atlantic Llc
7.17%
RTW INVESTMENTS, LLC
6.85%
Vanguard Group Inc
5.66%

Akero Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 10 October

    Fri, 04:29 PM

    -

    Akero agrees to a $5.2 billion takeover by Novo Nordisk, enhancing its position in metabolic treatments.

    Sat, 04:08 AM

    -

    Analyst downgrades Akero to Hold with a $58 price target amid regulatory uncertainties post-Novo acquisition.

Insights on Akero Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, AKRO stock has moved up by 80.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 951.8% return, outperforming this stock by 924.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 161.7% return, outperforming this stock by 81.6%

About Akero Therapeutics Inc

Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH). Efruxifermin (EFX), its lead product candidate for MASH, is being evaluated in three ongoing Phase 3 studies: SYNCHRONY Outcomes in patients with compensated cirrhosis (F4) due to MASH, SYNCHRONY Histology in patients with pre-cirrhotic (F2-F3 fibrosis) MASH, and SYNCHRONY Real-World in patients with MASH (F1-F4). The Phase 3 SYNCHRONY program builds on the results of two Phase 2b clinical trials, the HARMONY study in patients with pre-cirrhotic MASH and the SYMMETRY study in patients with compensated cirrhosis due to MASH. EFX is an analog of fibroblast growth factor 21 (FGF21), which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body.
OrganisationAkero Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Akero Therapeutics Inc share price today?

Akero Therapeutics Inc share price today is $54.65 as on at the close of the market. Akero Therapeutics Inc share today touched a day high of $54.83 and a low of $54.37.

What is the 52 week high and 52 week low for Akero Therapeutics Inc share?

Akero Therapeutics Inc share touched a 52 week high of $58.4 on and a 52 week low of $21.34 on . Akero Therapeutics Inc stock price today i.e. is closed at $54.65,which is 6.42% down from its 52 week high and 156.09% up from its 52 week low.

How to invest in Akero Therapeutics Inc Stock (AKRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Akero Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Akero Therapeutics Inc Shares that will get you 0.0274 shares as per Akero Therapeutics Inc share price of $54.65 per share as on December 9, 2025 at 2:29 am IST.

What is the minimum amount required to buy Akero Therapeutics Inc Stock (AKRO) from India?

Indian investors can start investing in Akero Therapeutics Inc (AKRO) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Akero Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Akero Therapeutics Inc share’s latest price of $54.65 as on December 9, 2025 at 2:29 am IST, you will get 0.1830 shares of Akero Therapeutics Inc. Learn more about fractional shares .